Coastal Biotech

Who Is Behind the Company

Coastal Biotech is led by CEO and co-founder Lavine Irvine, who brings experience in data science and operational efficiency from roles at GSK and S&P Global Ratings. The R&D function is supported by Danford Mkunda, who has a background in biochemistry and biopolymers. The company is listed as having two co-founders [SAIS Accelerator, retrieved 2026] [Munich Startup, retrieved 2026].

Data Accuracy: YELLOW -- Key details like founding date and full founding team are not confirmed by primary corporate sources.

What an Investor Needs First

Coastal Biotech is an early-stage marine biotech company building an integrated manufacturing operation for seaweed-derived agricultural inputs, a bet that leverages a local resource in Zanzibar to address global demand for sustainable crop solutions [Perplexity Sonar Pro Brief, retrieved 2026]. The company's focus on converting macroalgae into organic biostimulants and crop protectants positions it at the intersection of climate-resilient agriculture and the bioeconomy.

The venture is structured as a fully integrated manufacturer, a model that includes R&D, formulation design, and contract manufacturing [NextCapital, retrieved 2026] [Perplexity Sonar Pro Brief, retrieved 2026]. This end-to-end approach is ambitious for a pre-seed African startup and suggests a strategy to capture more value from the seaweed supply chain rather than just selling raw extracts.

Public traction is currently demonstrated through accelerator participation and hiring intent. The company was part of the 2025 SAIS Accelerator cohort and is actively recruiting for a specialized Seaweed Biotechnologist role [SAIS Accelerator, retrieved 2026] [Perplexity Sonar Pro Brief, retrieved 2026]. No priced equity funding rounds have been publicly reported.

Data Accuracy: YELLOW -- Core product claims and accelerator participation are confirmed; founder background is partially corroborated; funding and customer details are not publicly available.

Inside the Company

Coastal Biotech Ltd. is a marine biotechnology company headquartered in Zanzibar, Tanzania, focused on converting locally sourced seaweed into agricultural and industrial products. The company's founding narrative centers on leveraging Zanzibar's established seaweed farming sector to create higher-value, sustainable alternatives to chemical inputs [Perplexity Sonar Pro Brief, retrieved 2026].

Key operational milestones point to an early-stage build phase. The company participated in the SAIS Accelerator program in 2025 [SAIS Accelerator, retrieved 2026]. A development plan was reported in late 2024, with an announcement of intentions to build a new seaweed fertilizer factory [IPP Media / The Guardian (Tanzania), Dec 2024]. The company is currently recruiting for a specialized Seaweed Biotechnologist role [Perplexity Sonar Pro Brief, retrieved 2026].

Data Accuracy: YELLOW -- Key details like founding date and full founding team are not confirmed by primary corporate sources. Operational milestones are cited from accelerator and local news reports.

Under the Hood

The company's public positioning centers on a vertically integrated model for converting seaweed into a suite of sustainable agricultural and industrial products. Coastal Biotech develops organic biostimulants and crop protectants from locally sourced macroalgae. Its product portfolio extends into three broad categories: biostimulants for plant resilience, functional ingredients for human and animal food and feed, and bio-based materials like biopolymers for industrial applications [Perplexity Sonar Pro Brief]. The firm also offers formulation design and contract manufacturing services [Perplexity Sonar Pro Brief].

Technical differentiation appears to hinge on proprietary processing of Zanzibar's native seaweed species. An open job posting for a Seaweed Biotechnologist specializing in tissue culture indicates active R&D into bioactive compounds and marine biopolymers [Perplexity Sonar Pro Brief]. The company claims its integrated operations are carbon-negative [Perplexity Sonar Pro Brief]. A reported plan to build a new seaweed fertilizer factory points to intended physical expansion of manufacturing capacity [IPP Media / The Guardian (Tanzania), Dec 2024].

Data Accuracy: YELLOW -- Product claims are consistent across multiple startup profiles, but specific technical specifications, efficacy data, and details of the contract manufacturing service are not publicly detailed.

Market Research

The push for sustainable agriculture is creating a tangible market for biological inputs. The global biostimulants market was valued at approximately $3.2 billion in 2022 and is projected to grow at a compound annual rate of 12.1% through 2032 [Perplexity Sonar Pro Brief].

Key demand drivers include regulatory bans on certain synthetic pesticides and the need for climate-resilient farming practices. The company's focus on local seaweed sourcing in Zanzibar taps into a broader macro trend of regionalizing supply chains and creating circular bioeconomies.

Metric	Value
Global Biostimulants Market 2022	$3.2B
Projected CAGR 2022-2032	12.1%

Data Accuracy: YELLOW -- Market sizing is drawn from an aggregated third-party report on the global biostimulant category, not the company's specific regional segment.

Competition and Substitutes

Coastal Biotech operates in a nascent segment, positioning itself as an integrated, locally-sourced producer of seaweed-derived agricultural inputs and biomaterials.

• Global Biostimulant and Agrochemical Incumbents: Multinationals like Bayer and Syngenta offer established efficacy but face regulatory and consumer pressure regarding environmental impact [SAIS Accelerator].
• Specialized Biostimulant Producers: Firms like Valagro and Fyteko develop plant biostimulants from various natural sources.
• Regional Agricultural Input Distributors: Local distributors in East Africa control farmer relationships but typically lack proprietary product development.
• Adjacent Substitutes in Biomaterials: Competitors like Algix or Checkerspot target higher-value industrial and consumer goods markets.

Coastal Biotech's current defensible edge appears to be its integrated, local model. This edge depends on maintaining exclusive or preferential relationships with local seaweed farmers and achieving consistent, scaled production.

Data Accuracy: YELLOW -- Competitive mapping is inferred from the company's described product categories and target markets; no direct competitor names are confirmed in public sources.

Opportunity

If Coastal Biotech can successfully industrialize its model of converting local seaweed into high-value agricultural and industrial inputs, it could establish a first-mover position in a nascent segment of the African bioeconomy. The company is building a manufacturing platform that could supply a range of biostimulants, crop protectants, and biomaterials from a single, localized feedstock source.

Scenario	What happens	Catalyst
Anchor Contract with a Regional Agribusiness	Coastal Biotech secures a long-term supply agreement with a major fertilizer blender or crop input distributor.	A successful pilot deployment with a cooperative or commercial farm.
Technology Licensing to Global Ingredient Players	Proprietary methods for extracting or formulating specific high-value compounds are licensed to multinational ingredient corporations.	Publication of peer-reviewed research or granting of a key process patent.

Data Accuracy: YELLOW -- Opportunity analysis is based on the company's stated model and services; specific catalysts and comparable valuations are inferred from the broader industry context.

Sources

1. [Perplexity Sonar Pro Brief, retrieved 2026] Coastal Biotech Brief | https://coastalbiotech.co.tz/
2. [SAIS Accelerator, retrieved 2026] Coastal Biotech - SAIS Accelerator | https://sais-accelerator.com/start-up-profile/coastal-biotech/
3. [NextCapital, retrieved 2026] Coastal Biotech - by Sheriff Alimi and Aisha Aliu | https://nextcapital.substack.com/p/coastal-biotech
4. [Munich Startup, retrieved 2026] Coastal Biotech - Munich Startup | https://www.munich-startup.de/en/startups/coastal-biotech/
5. [IPP Media / The Guardian (Tanzania), Dec 2024] Seaweed fertiliser: Coastal Biotech plans new factory |